Pure Global

Qizhe α fetoprotein in vitro reagent group - Taiwan Registration 720b2528f34b14c11c10e47299d90308

Access comprehensive regulatory information for Qizhe α fetoprotein in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 720b2528f34b14c11c10e47299d90308 and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
720b2528f34b14c11c10e47299d90308
Registration Details
Taiwan FDA Registration: 720b2528f34b14c11c10e47299d90308
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qizhe α fetoprotein in vitro reagent group
TW: 啟哲α胎蛋白體外試劑組
Risk Class 2
Cancelled

Registration Details

720b2528f34b14c11c10e47299d90308

Company Information

Taiwan, Province of China

Product Details

Qualitative detection of AFP in human serum.

C Immunology and microbiology

C.6010 腫瘤相關抗原免疫試驗系統

Contract manufacturing;; Domestic

Dates and Status

Dec 11, 2013

Dec 07, 2016

Apr 25, 2018

Cancellation Information

Logged out

自行鍵入